Navigation Links
Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
Date:10/12/2009

CHICAGO, Oct. 12 /PRNewswire/ -- Ethicon Endo-Surgery, Inc., today unveiled its broad portfolio of energy delivery devices at the 95th Annual Clinical Congress of the American College of Surgeons (ACS). The complementary energy technologies of worldwide leading HARMONIC® ultrasonic and ENSEAL® advanced bipolar devices provide surgeons with multiple energy delivery options that provide superior energy application for desired tissue effects to meet specific surgical needs across multiple surgical specialties. Ethicon Endo-Surgery acquired the ENSEAL® technology in October 2008; the ACS Annual Clinical Congress marks the full integration of the ENSEAL® product line into the Ethicon Endo-Surgery energy portfolio.

"I believe energy is the future of surgery, which is why we're seeing such significant advances in both bipolar and ultrasonic energy, which enhance the experience of surgeons and patients alike," said Michael J. Stamos, MD, FACS, FASCRS, chief, Division of Colon & Rectal Surgery, Department of Surgery, University of California, Irvine. "Since each patient case is unique, it is imperative to understand the distinctive attributes of each different energy technology. It also is critical to have the confidence and flexibility to choose the right modality to achieve optimal outcomes for both patients and for surgeons in terms of greater precision and control, maximized surgical efficiency and best tissue effect."

As energy delivery device options have evolved, they have enabled more efficient and minimally invasive surgical techniques. Ethicon Endo-Surgery, originally with HARMONIC® technology and now ENSEAL®, has led this evolution of surgery by working directly with surgeons to develop innovations, enabling greater functionality, controlled tissue sealing, and minimization of tissue trauma.

With its bipolar technology, ENSEAL® offers superior control in large vessel sealing for surgical procedures in general, colorectal, gynecology, and urology where minimal tissue damage is critical. Pre-clinical studies have shown ENSEAL® laparoscopic and open devices contain energy spread and are faster at sealing and transecting than competitive devices, while offering exceptional large vessel sealing (up to and including 7mm blood vessels).

As the leading ultrasonic cutting and coagulating surgical device used in more than 8 million surgical procedures worldwide since 1995, HARMONIC® allows precise application of ultrasonic energy in advanced laparoscopic and open procedures, and minimizes adjacent tissue damage to the patient. These devices are versatile and help the surgeon perform multiple surgical tasks with a single device that can lead to overall efficiency improvement over traditional techniques. HARMONIC® is indicated for multiple specialties and surgeries, including laparoscopic and open technique procedures within general, colorectal, gynecologic and urologic procedures, and often is credited with being the first device to enable some advanced laparoscopic procedures that general surgeons perform today.

"An increasing number of surgeons are applying the new technologies as standard of care for both laparoscopic and open procedures," said Kevin Lobo, worldwide president, Ethicon Endo-Surgery. "By offering both an ultrasonic and advanced bipolar technology, Ethicon Endo-Surgery delivers options to meet the needs of traditional and emerging surgical techniques."

About Ethicon Endo-Surgery

Ethicon Endo-Surgery develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at www.ethiconendo.com.

SOURCE Ethicon Endo-Surgery, Inc.


'/>"/>
SOURCE Ethicon Endo-Surgery, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Companys Toolbox
2. First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
3. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
4. Ethicon Endo-Surgery Launches New Echelon Flex(TM) Endopath(R) Stapler That Delivers Echelon(TM) Compression, Now With Natural Articulation
5. Oregon Tourism Commission Unveils New Online Customer Service Training Program
6. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
7. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
8. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
9. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
10. Boehringer Ingelheim Unveils Diabetes Pipeline
11. GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... 2016  Granger Diagnostics today announced immediate availability of ... infections. This test ensures discovery of ALL bacteria, ... test requires only a simple swab of the wound ... G. Bostwick , MD, Chief Medical Officer, described ... "We are excited to make available, for the ...
(Date:5/25/2016)... , May 25, 2016 MedDay, ... disorders, announces that an oral presentation entitled "High doses of ... MS-SPI trial" will be given by Professor Ayman Tourbah ... 2nd Congress of the European Academy of Neurology (EAN) in ... and related disorders 3" will take place on Sunday, 29 ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology:
(Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... the factors of a stroke, which we as a society can control and change. ... a stroke occurs nearly every 40 seconds within the United States. Plus, with an ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... to help educate the many who are unaware of the plight of aphasia. ... will run within the “Stroke Awareness” campaign. , The link between stroke and ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... interest stories, courtesy of leaders in the nursing and health care industry. It ... leading advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning ...
Breaking Medicine News(10 mins):